Sequence information
Variant position: 241 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 766 The length of the canonical sequence.
Location on the sequence:
ELHVEVLENVPLTTHNFVRK
T FFTLAFCDFCRKLLFQGFRC
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human ELHVEVLENVPLTTHNFVRKT FFTLAFCDFCRKLLFQGFRC
Mouse ELHVEVLENVPLTTHNFVRKT FFTLAFCDFCRKLLFQGFRC
Chicken ELHVEVLENVPLTTHNFVRKT FFTLAFCDFCRKLLFQGFRC
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Literature citations
Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
Schulz A.L.; Albrecht B.; Arici C.; van der Burgt I.; Buske A.; Gillessen-Kaesbach G.; Heller R.; Horn D.; Hubner C.A.; Korenke G.C.; Konig R.; Kress W.; Kruger G.; Meinecke P.; Mucke J.; Plecko B.; Rossier E.; Schinzel A.; Schulze A.; Seemanova E.; Seidel H.; Spranger S.; Tuysuz B.; Uhrig S.; Wieczorek D.; Kutsche K.; Zenker M.;
Clin. Genet. 73:62-70(2008)
Cited for: VARIANTS CFC1 PRO-241; PRO-244; PRO-246; ARG-257; LYS-262; SER-468; GLU-469; GLU-499; ASN-499; ASP-580; ASP-581 AND LEU-595;
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
Sarkozy A.; Carta C.; Moretti S.; Zampino G.; Digilio M.C.; Pantaleoni F.; Scioletti A.P.; Esposito G.; Cordeddu V.; Lepri F.; Petrangeli V.; Dentici M.L.; Mancini G.M.; Selicorni A.; Rossi C.; Mazzanti L.; Marino B.; Ferrero G.B.; Silengo M.C.; Memo L.; Stanzial F.; Faravelli F.; Stuppia L.; Puxeddu E.; Gelb B.D.; Dallapiccola B.; Tartaglia M.;
Hum. Mutat. 30:695-702(2009)
Cited for: VARIANT LPRD3 PRO-241; VARIANTS NS7 ARG-241; MET-241; CYS-531 AND VAL-597; VARIANTS CFC1 PHE-245; PRO-246; ARG-257; LYS-275; GLU-469; PHE-485; ASN-499; LYS-501; PRO-525; LEU-595; ARG-599; GLN-601; GLU-638 AND ARG-709;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.